Latest total liabilities for ADRX: $350M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
ADARx Pharmaceuticals posts a total liabilities of $350M as of September 2026. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
Total Liabilities is one piece of ADARx Pharmaceuticals's financial statement story. At $350M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for ADRX's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; ADARx Pharmaceuticals's other metric pages and overview cover the third.